Literatur

[1] Pironi L, Cuerda C, Jeppesen PB, et al. ESPEN guideline on chronic intestinal failure in adults - Update 2023. Clin Nutr 2023;42(10):1940-20210

[2] Massironi S, Cavalcoli F, Rausa E, et al. Understanding short bowel syndrome: current status and future perspectives. Dig Liver Dis 2020;52(3):253-61

[3] von Websky MW, Liermann U, Buchholz BM, et al. Das Kurzdarmsyndrom in Deutschland. Der Chirurg 2014;85(5):433-9

[4] Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003;22(5):445-52

[5] Lamprecht G, Pape UF, Witte M, et al. S3-Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin e. V. in Zusammenarbeit mit der AKE, der GESKES und der DGVS. Aktuelle Ernährungsmedizin 2014;39(02):e57-e71

[6] Pape UF, Maasberg S. Intestinale Rehabilitation bei Kurzdarmsyndrom und chronischem Darmversagen. Dtsch Med Wochenschr 2019;144(15):1061-6

[7] Nikoupour H, Theodorou A, Arasteh P, et al. Update on surgical management of enteroatmospheric fistulae in intestinal failure patients. Curr Opin Organ Transplant 2022;27(2):137-43

[8] Leuenberger M, Siewert S, Meier R, et al. Das Kurzdarmsyndrom: Eine interdisziplinäre Herausforderung. Aktuelle Ernährungsmedizin 2006;31(05):235-42

[9] Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr 2015;34(2):171-80

[10] Donohoe CL, Reynolds JV. Short bowel syndrome. The Surgeon 2010;8(5):270-9

[11] Duggan CP, Jaksic T. Pediatric intestinal failure. N Engl J Med 2017;377(7):666-75

[12] Thakur A, Chiu C, Quiros-Tejeira RE, et al. Morbidity and mortality of short-bowel syndrome in infants with abdominal wall defects. Am Surg 2002;68(1):75-9

[13] Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117(5):1043-50

[14] Pevny S, Maasberg S, Rieger A, et al. Experience with teduglutide treatment for short bowel syndrome in clinical practice. Clin Nutr 2019;38(4):1745-55

[15] Blüthner E, Bednarsch J, Pape UF, et al. Advanced liver function assessment in patients with intestinal failure on long-term parenteral nutrition. Clin Nutr 2020;39(2):540-7

[16] Knappe-Drzikova B, Maasberg S, Vonderbeck D, et al. Malnutrition predicts long-term survival in hospitalized patients with gastroenterological and hepatological diseases. Clin Nutr ESPEN 2019;30:26-34

[17] Lamprecht G. 2018. "65 Kurzdarmsyndrom (Darminsuffizienz und Darmversagen)." In Ernährungsmedizin. Stuttgart: Georg Thieme Verlag.

[18] Adolph M PM, Reimer T. 2018. "34 Klinische enterale und parenterale Ernährung (inkl. Technik und Sonden)." In Ernährungsmedizin. Stuttgart: Georg Thieme Verlag.

[19] Blüthner E, Pape UF, Stockmann M, et al. Assessing non-invasive liver function in patients with intestinal failure receiving total parenteral nutrition – results from the Prospective PNLiver Trial. Nutrients 2020;12(5)

[20] Staun M, Pironi L, Bozzetti F, et al. ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009;28(4):467-79

[21] Pironi L, Boeykens K, Bozzetti F, et al. ESPEN guideline on home parenteral nutrition. Clin Nutr 2020;39(6):1645-66

[22] Pironi L, Konrad D, Brandt C, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey. Clin Nutr 2018;37(2):728-38

[23] Harris JA, Benedict FG. A Biometric study of human basal metabolism. Proceedings of the National Academy of Sciences of the United States of America 1918;4(12):370-3

[24] Mathias D. Physical Activity Level. (Hrsg.) Fit und gesund von 1 bis Hundert: Ernährung und Bewegung – Aktuelles medizinisches Wissen zur Gesundheit. Springer Berlin Heidelberg, Berlin, Heidelberg, 2018;15

[25] Rote Liste. Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und bestimmter Medizinprodukte) 2023. www.rote-liste.de, abgerufen am 26.10.2023

[26] Brubaker PL. Glucagon-like peptide-2 and the regulation of intestinal growth and function. Compr Physiol 2018;8(3):1185-210

[27] Jeppesen PB, Pertkiewicz M, Messing B, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 2012;143(6):1473-81.e3

[28] Pape UF, Maasberg S, Pascher A. Pharmacological strategies to enhance adaptation in intestinal failure. Curr Opin Organ Transplant 2016;21(2):147-52

[29] DaCambra MP, Yusta B, Sumner-Smith M, et al. Structural determinants for activity of glucagon-like peptide-2. Biochemistry 2000;39(30):8888-94

[30] Pape UF, Iyer KR, Jeppesen PB, et al. Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials. Therap Adv Gastroenterol 2020;13:1756284820905766

[31] Schwartz LK, O'Keefe SJ, Fujioka K, et al. Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome. Clin Transl Gastroenterol 2016;7(2):e142

[32] Schoeler M, Klag T, Wendler J, et al. GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting. Therapeutic advances in gastroenterology 2018;11:1756284818793343

[33] Naimi RM, Hvistendahl M, Enevoldsen LH, et al. Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. Lancet Gastroenterol Hepatol 2019;4(5):354-63

[34] Eliasson J, Hvistendahl MK, Freund N, et al. Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: findings from a placebo-controlled, randomized phase 2 trial. JPEN J Parenter Enteral Nutr 2021; 10.1002/jpen.2223

[35] Cserni T, Biszku B, Guthy I, et al. The first clinical application of the spiral intestinal lengthening and tailoring (silt) in extreme short bowel syndrome. Journal of Gastrointestinal Surgery 2014;18(10):1852-7

[36] Hommel MJ, van Baren R, Haveman JW. Surgical management and autologous intestinal reconstruction in short bowel syndrome. Best Practice & Research Clinical Gastroenterology 2016;30(2):263-80

[37] Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003;38(3):425-9

[38] Frongia G, Kessler M, Weih S, et al. Comparison of LILT and STEP procedures in children with short bowel syndrome — a systematic review of the literature. J Pediatr Surg 2013;48(8):1794-805

[39] Bianchi A. Intestinal loop lengthening – a technique for increasing small intestinal length. J Pediatr Surg 1980;15(2):145-51

[40] Lal S, Pironi L, Wanten G, et al. Clinical approach to the management of intestinal failure associated liver disease (IFALD) in adults: a position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN. Clin Nutr 2018;37(6 Pt A):1794-7

[41] Gahlot R, Nigam C, Kumar V, et al. Catheter-related bloodstream infections. International journal of critical illness and injury science 2014;4(2):162-7